Pathfinder Cell Therapy, Inc.
PFND
Rank in Stocks
#34007
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in... Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$66.72K
Change (1 day)
0.00%
Change (1 year)
9,900.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Pathfinder Cell Therapy, Inc. (PFND)
Category
Healthcare
Operating Margin for Pathfinder Cell Therapy, Inc. (PFND)
Operating Margin as of November 2026 TTM: 0.00%
According to Pathfinder Cell Therapy, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2014 the company had an operating margin of 0.00%.
Operating Margin history for Pathfinder Cell Therapy, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2014 | 0.00% | -100.00% |
| 2013 | -2,961.11% | 63.87% |
| 2012 | -1,807.02% | -133.60% |
| 2011 | 5,378.08% | -840.32% |
| 2010 | -726.45% | -36.52% |
| 2009 | -1,144.44% | -54.71% |
| 2008 | -2,527.07% | -36.65% |
| 2007 | -3,988.81% | 24.90% |
| 2006 | -3,193.66% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | -100.00% |
| 2001 | -3,071.43% | 71.13% |
| 2000 | -1,794.83% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Pathfinder Cell Therapy, Inc.'s operating margin
What was Pathfinder Cell Therapy, Inc.'s operating margin in 2014?
In 2014, Pathfinder Cell Therapy, Inc.'s operating margin was 0.00%, compared with -2,961.11% in 2013.
How has Pathfinder Cell Therapy, Inc.'s operating margin changed since 2009?
From 2009 to 2014, Pathfinder Cell Therapy, Inc.'s operating margin was highest in 2011 (5,378.08%) and lowest in 2013 (-2,961.11%).
How does Pathfinder Cell Therapy, Inc.'s operating margin compare with similar companies?
Pathfinder Cell Therapy, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.